Medical research in children, an issue causing U.S. regulators to balance safety concerns against the need for more trials, is getting scrutiny that may lead to changes in federal guidelines.
The U.S. Food and Drug Administration is reviewing how to do pediatric studies on drugs for disorders such as asthma, on potential AIDS vaccines and for the medical use of stem cells, said Norman Fost, a pediatrics professor at the University of Wisconsin who’s chairing the panel. A two-day meeting on the questions starts today in Gaithersburg, Maryland.